ProMIS Neurosciences Inc. SEC filings PMN
ProMIS Neurosciences Inc. has 373 filings in SEC EDGAR's recent list, going back to Aug 29, 2006. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 20, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 30, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Other events
|
Dec 16, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 24, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 19, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 24, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 19, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 22, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 22, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Other events
|
Jul 7, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 27, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 8, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 24, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Other events
|
Jul 29, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 30, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 3, 2024 | Dec 30, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Dec 8, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 22, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 14, 2023 | Jul 13, 2023 |
| 8-K |
Current report
Other events
|
Jul 10, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Other events
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Other events
|
Apr 10, 2023 | Apr 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 16, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 17, 2022 | Oct 11, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Sep 13, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Auditor change
|
Jul 29, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Other events
|
Jul 8, 2022 | Jul 6, 2022 |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto, Ontario, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1374339
- Former names
- AMORFIX LIFE SCIENCES LTD (until Nov 3, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.